2nd Quarter - Report — UCB, INC. for UCB, INC. (2025)

Firm

UCB, INC.

Client

UCB, INC.

Income

—

Expenses

$750,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare Home Infusion

Lobbyist	Covered position, as disclosed
JED PERRY	—

Contacted: HOUSE OF REPRESENTATIVES

Pharmacy PHA

HR 946 - ORPHAN Cures Act S 1862 - ORPHAN Cures Act Drug Pricing

Lobbyist	Covered position, as disclosed
JED PERRY	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 946 (119th)

Taxation/Internal Revenue Code TAX

HR 1

Lobbyist	Covered position, as disclosed
JED PERRY	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1 (119th)

Tariff (miscellaneous tariff bills) TAR

Tariffs

Lobbyist	Covered position, as disclosed
JED PERRY	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.